Skip to content
The Policy VaultThe Policy Vault

Imuldosa subcutaneous — Cigna

All Conditions

Initial criteria

  • Patient meets the standard Inflammatory Conditions – Ustekinumab Subcutaneous Prior Authorization Policy criteria.

Reauthorization criteria

  • Patient continuing therapy meets the standard Inflammatory Conditions – Ustekinumab Subcutaneous Prior Authorization Policy criteria.

Approval duration

as directed or 1 year